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ABSTRACT 
Rosmarinic acid (RA) is a highly valued natural phenolic compound that is very commonly 
found in plants of the families Lamiaceae and Boraginaceae, including Coleus blumei, 
Heliotropium foertherianum, Rosmarinus officinalis, Perilla frutescens, and Salvia officinalis. 
RA is also found in other members of higher plant families and in some fern and horned 
liverwort species. The biosynthesis of RA is catalyzed by the enzymes phenylalanine ammonia 
lyase and cytochrome P450-dependent hydroxylase using the amino acids tyrosine and 
phenylalanine. Chemically, RA can be produced via methods involving the esterification of 
3,4-dihydroxyphenyllactic acid and caffeic acid. Some of the derivatives of RA include melitric 
acid, salvianolic acid, lithospermic acid, and yunnaneic acid. In plants, RA is known to have 
growth-promoting and defensive roles. Studies have elucidated the varied pharmacological 
potential of RA and its derived molecules, including anticancer, antiangiogenic, anti-
inflammatory, antioxidant, and antimicrobial activities. The demand for RA is therefore, very 
high in the pharmaceutical industry, but this demand cannot be met by plants alone because 
RA content in plant organs is very low. Further, many plants that synthesize RA are under 
threat and near extinction owing to biodiversity loss caused by unscientific harvesting, over-
collection, environmental changes, and other inherent features. Moreover, the chemical 
synthesis of RA is complicated and expensive. Alternative approaches using biotechnological 
methodologies could overcome these problems. This review provides the state of the art 
information on the chemistry, sources, and biosynthetic pathways of RA, as well as its 
anticancer properties against different cancer types. Biotechnological methods are also 
discussed for producing RA using plant cell, tissue, and organ cultures and hairy-root cultures 
using flasks and bioreactors. The recent developments and applications of the functional 
genomics approach and heterologous production of RA in microbes are also highlighted. This 
chapter will be of benefit to readers aiming to design studies on RA and its applicability as an 
anticancer agent. 
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